JP2022500470A5 - - Google Patents

Info

Publication number
JP2022500470A5
JP2022500470A5 JP2021515030A JP2021515030A JP2022500470A5 JP 2022500470 A5 JP2022500470 A5 JP 2022500470A5 JP 2021515030 A JP2021515030 A JP 2021515030A JP 2021515030 A JP2021515030 A JP 2021515030A JP 2022500470 A5 JP2022500470 A5 JP 2022500470A5
Authority
JP
Japan
Prior art keywords
independently
alkyl
cycloalkyl
haloalkyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021515030A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500470A (ja
JP7427658B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051274 external-priority patent/WO2020060915A1/en
Publication of JP2022500470A publication Critical patent/JP2022500470A/ja
Publication of JP2022500470A5 publication Critical patent/JP2022500470A5/ja
Application granted granted Critical
Publication of JP7427658B2 publication Critical patent/JP7427658B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515030A 2018-09-18 2019-09-16 Lpaアンタゴニストとしてのシクロペンチル酸 Active JP7427658B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862732590P 2018-09-18 2018-09-18
US62/732,590 2018-09-18
PCT/US2019/051274 WO2020060915A1 (en) 2018-09-18 2019-09-16 Cyclopentyl acids as lpa antagonists

Publications (3)

Publication Number Publication Date
JP2022500470A JP2022500470A (ja) 2022-01-04
JP2022500470A5 true JP2022500470A5 (cg-RX-API-DMAC7.html) 2023-11-08
JP7427658B2 JP7427658B2 (ja) 2024-02-05

Family

ID=68073223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515030A Active JP7427658B2 (ja) 2018-09-18 2019-09-16 Lpaアンタゴニストとしてのシクロペンチル酸

Country Status (7)

Country Link
US (1) US12209072B2 (cg-RX-API-DMAC7.html)
EP (1) EP3852746B1 (cg-RX-API-DMAC7.html)
JP (1) JP7427658B2 (cg-RX-API-DMAC7.html)
KR (1) KR102950123B1 (cg-RX-API-DMAC7.html)
CN (1) CN113473985A (cg-RX-API-DMAC7.html)
ES (1) ES2946657T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020060915A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102800284B1 (ko) * 2018-09-18 2025-04-23 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 시클로헵틸 산
JP7412424B2 (ja) * 2018-09-18 2024-01-12 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのオキサビシクロ酸
CN111434655A (zh) * 2019-01-15 2020-07-21 武汉朗来科技发展有限公司 溶血磷脂酸受体拮抗剂及其制备方法
JP2022522534A (ja) 2019-04-02 2022-04-19 アリゴス セラピューティクス インコーポレイテッド Prmt5を標的にする化合物
CN114728168B (zh) 2019-11-15 2024-04-09 吉利德科学公司 三唑氨基甲酸酯吡啶基磺酰胺作为lpa受体拮抗剂及其用途
US11702407B2 (en) 2020-06-03 2023-07-18 Gilead Sciences, Inc. LPA receptor antagonists and uses thereof
TWI843503B (zh) * 2020-06-03 2024-05-21 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
IL300525A (en) * 2020-08-11 2023-04-01 Viva Star Biosciences Ltd Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists
CN117751106A (zh) * 2021-04-30 2024-03-22 唯久生物技术(苏州)有限公司 作为lpa拮抗剂的新型三唑-吡啶取代的吡咯烷基和四氢-2h-吡喃基乙酸化合物
AU2022273631B2 (en) * 2021-05-11 2025-04-17 Gilead Sciences, Inc. Lpa receptor antagonists and uses thereof
KR20240007233A (ko) 2021-05-13 2024-01-16 길리애드 사이언시즈, 인코포레이티드 Lpa 수용체 길항제 및 이의 용도
KR20240038004A (ko) * 2021-07-20 2024-03-22 투오지에 바이오텍 (상하이) 컴퍼니 리미티드 Lpa1 소분자 길항제
US11939318B2 (en) 2021-12-08 2024-03-26 Gilead Sciences, Inc. LPA receptor antagonists and uses thereof
TW202342017A (zh) 2022-02-25 2023-11-01 美商洛子峰生物有限公司 用於治療與lpa受體活性相關的病狀的化合物及組合物
US20260226025A1 (en) * 2023-01-19 2026-08-06 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceutically acceptable salt and crystal form of triazole compound, and preparation method therefor
IL326963A (en) * 2023-09-08 2026-05-01 Haisco Pharmaceutical Group Co Ltd LPAR1 antagonist and its use
WO2026061483A1 (zh) * 2024-09-19 2026-03-26 西藏海思科制药有限公司 一种lpar1拮抗剂及其用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364659B1 (en) 2001-02-08 2009-11-11 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
US20080186971A1 (en) 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
GB2470833B (en) 2009-06-03 2011-06-01 Amira Pharmaceuticals Inc Polycyclic antagonists of lysophosphatidic acid receptors
JP2013501064A (ja) 2009-08-04 2013-01-10 アミラ ファーマシューティカルス,インコーポレーテッド リゾホスファチジン酸受容体アンタゴニストとしての化合物
GB2474120B (en) 2009-10-01 2011-12-21 Amira Pharmaceuticals Inc Compounds as Lysophosphatidic acid receptor antagonists
GB2474748B (en) 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists
TW201120016A (en) 2009-12-08 2011-06-16 Abbott Lab Novel oxadiazole compounds
CN107721940A (zh) 2010-12-07 2018-02-23 阿米拉制药公司 多环lpa1拮抗剂及其使用
WO2012078593A2 (en) 2010-12-07 2012-06-14 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonists and uses thereof
US9527807B2 (en) 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
WO2012138648A1 (en) 2011-04-06 2012-10-11 Irm Llc Compositions and methods for modulating lpa receptors
WO2013070879A1 (en) 2011-11-10 2013-05-16 Bristol-Myers Squibb Company Methods for treating spinal cord injury with lpa receptor antagonists
HK1206339A1 (en) 2012-06-20 2016-01-08 霍夫曼-拉罗奇有限公司 N-aryltriazole compounds as lpar antagonists
SG11201407220YA (en) 2012-06-20 2014-12-30 Hoffmann La Roche N-alkyltriazole compounds as lpar antagonists
EP3010908A1 (en) * 2013-02-20 2016-04-27 E. I. du Pont de Nemours and Company Fungicidal pyrazoles
US8962660B2 (en) 2013-03-14 2015-02-24 Bristol-Myers Squibb Company Oxabicyclo [2.2.2] acid GPR120 modulators
SG11201507459YA (en) 2013-03-15 2015-10-29 Epigen Biosciences Inc Heterocyclic compounds useful in the treatment of disease
JP2017095366A (ja) 2015-11-18 2017-06-01 持田製薬株式会社 新規ビアリールアミド誘導体
AR108838A1 (es) 2016-06-21 2018-10-03 Bristol Myers Squibb Co Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
PE20210655A1 (es) 2017-12-19 2021-03-31 Bristol Myers Squibb Co Carbamoil ciclohexil acidos ligados a n de triazol como antagonistas de lpa
US11319309B2 (en) 2017-12-19 2022-05-03 Bristol-Myers Squibb Company Cyclohexyl acid isoxazole azines as LPA antagonists
JP7212047B2 (ja) 2017-12-19 2023-01-24 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
JP7369125B2 (ja) 2017-12-19 2023-10-25 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのイソキサゾールo-架橋カルバモイルシクロヘキシル酸
KR102725744B1 (ko) 2017-12-19 2024-11-01 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 시클로헥실 산 피라졸 아진
ES2962367T3 (es) 2017-12-19 2024-03-18 Bristol Myers Squibb Co Acidos carbamoil ciclohexílicos N-enlazados a pirazol como antagonistas de receptores del ácido lisofosfatídico (LPA)
JP7202383B2 (ja) 2017-12-19 2023-01-11 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのピラゾールo-架橋カルバモイルシクロヘキシル酸
US11447475B2 (en) 2017-12-19 2022-09-20 Bristol-Myers Squibb Company Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
WO2019126087A1 (en) 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Cyclohexyl acid isoxazole azoles as lpa antagonists
JP7412424B2 (ja) 2018-09-18 2024-01-12 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのオキサビシクロ酸
KR102800284B1 (ko) 2018-09-18 2025-04-23 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 시클로헵틸 산

Similar Documents

Publication Publication Date Title
JP2022500469A5 (cg-RX-API-DMAC7.html)
JP2022500473A5 (cg-RX-API-DMAC7.html)
JP2021508686A5 (cg-RX-API-DMAC7.html)
JP2021507895A5 (cg-RX-API-DMAC7.html)
JP2021506878A5 (cg-RX-API-DMAC7.html)
JP2021507896A5 (cg-RX-API-DMAC7.html)
HRP20211918T1 (hr) Triazol n-vezane karbamoil cikloheksil kiseline kao lpa antagonisti
JP2021507900A5 (cg-RX-API-DMAC7.html)
JP2019518766A5 (cg-RX-API-DMAC7.html)
CN103443098B (zh) 作为溶血磷脂酸受体的拮抗剂的化合物、组合物及其应用
JP6534675B2 (ja) mIDH1阻害剤としてのベンズイミダゾール−2−アミン
JP2020528889A5 (cg-RX-API-DMAC7.html)
JP2023544476A5 (cg-RX-API-DMAC7.html)
JP6824954B2 (ja) mIDH1阻害剤としての5−ヒドロキシアルキルベンズイミダゾール
JP2019530669A5 (cg-RX-API-DMAC7.html)
JP2011523945A5 (cg-RX-API-DMAC7.html)
JP2020537657A5 (cg-RX-API-DMAC7.html)
JP2016515096A (ja) スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
JP7683930B2 (ja) セミカルバジド感受性アミンオキシダーゼ阻害剤の調製及びその応用
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP6783756B2 (ja) mIDH1阻害剤としてのベンゾイミダゾール−2−アミン
JP6830909B2 (ja) mIDH1阻害剤としてのN−メンチルベンズイミダゾール
JP2008513498A5 (cg-RX-API-DMAC7.html)
JP2017511794A5 (cg-RX-API-DMAC7.html)
AU2019362770A1 (en) Radioligands for imaging the LPA1 receptor